The Safety and Tolerability of Metformin plus Colesevelam in Drug-Naive Patients with Early Type 2 Diabetes Mellitus

被引:0
|
作者
Abby, Stacey L.
Garvey, W. Timothy
Handelsman, Yehuda
Fonseca, Vivian A.
Goldberg, Ronald B.
Rosenstock, Julio
Jones, Michael R.
Markiewicz, Magdalena
Jin, Xiaoping
Misir, Soamnauth
Nagendran, Sukumar
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A173 / A173
页数:1
相关论文
共 50 条
  • [31] Effect of Metformin Glycinate on Glycated Hemoglobin A1c Concentration and Insulin Sensitivity in Drug-Naive Adult Patients with Type 2 Diabetes Mellitus
    Gonzalez-Ortiz, Manuel
    Martinez-Abundis, Esperanza
    Robles-Cervantes, Jose A.
    Ramos-Zavala, Maria G.
    Barrera-Duran, Carmelita
    Gonzalez-Canudas, Jorge
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (12) : 1140 - 1144
  • [32] Tolerability of pioglitazone compared to metformin in patients with Type 2 diabetes mellitus.
    Herz, M
    Tan, MH
    Pavo, I
    Melnichenko, GA
    Shoustov, SB
    Gyimesi, A
    Varkonyi, T
    Johns, D
    Schluchter, BJ
    Widel, M
    DIABETOLOGIA, 2002, 45 : A251 - A252
  • [33] Safety of metformin in Type 2 diabetes mellitus
    Baigent, C
    Peto, R
    DIABETIC MEDICINE, 1999, 16 (02) : 89 - 90
  • [34] Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin - Glucose and lipid effects
    Bays, Harold E.
    Goldberg, Ronald B.
    Truitt, Kenneth E.
    Jones, Michael R.
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (18) : 1975 - 1983
  • [35] Initial Combination Therapy with Metformin plus Colesevelam Safely Achieves Glycemic and Lipid Goals with Less Diarrhea in Early Type 2 Diabetes Mellitus
    Rosenstock, Julio
    Fonseca, Vivian A.
    Garvey, W. Timothy
    Goldberg, Ronald B.
    Handelsman, Yehuda
    Abby, Stacey L.
    Lai, Yu-Ling
    Jin, Xiaoping
    Misir, Soamnauth
    Nagendran, Sukumar
    Jones, Michael R.
    DIABETES, 2010, 59 : A187 - A187
  • [36] Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
    Oh, Tae Jung
    Yu, Jae Myung
    Min, Kyung Wan
    Son, Hyun Shik
    Lee, Moon Kyu
    Yoon, Kun Ho
    Song, Young Duk
    Park, Joong Yeol
    Jeong, In Kyung
    Cha, Bong Soo
    Kim, Yong Seong
    Baik, Sei Hyun
    Kim, In Joo
    Kim, Doo Man
    Kim, Sung Rae
    Lee, Kwan Woo
    Park, Jeong Hyung
    Lee, In Kyu
    Park, Tae Sun
    Choi, Sung Hee
    Park, Sung Woo
    DIABETES & METABOLISM JOURNAL, 2019, 43 (03) : 276 - 286
  • [37] Effect of pantoprazole on insulin secretion in drug-naive patients with type 2 diabetes
    Gonzalez-Ortiz, Manuel
    Martinez-Abundis, Esperanza
    Mercado-Sesma, Arieh R.
    Alvarez-Carrillo, Rebeca
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (01) : E11 - E13
  • [38] Efficacy and tolerability of rosiglitazone and pioglitazone in drug-naive Japanese patients with type 2 diabetes mellitus: a double-blind, 28 weeks' treatment, comparative study
    Kikuchi, Masatoshi
    Kaku, Kohei
    Odawara, Masato
    Momomura, Shin-ichi
    Ishii, Ryutaro
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (06) : 1007 - 1016
  • [39] Safety and tolerability of pioglitazone in combination therapy with metformin and/or sulphonylureas in Diabetes mellitus Type 2.
    Satler, Miriam
    Nirnberger, Guenther
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S25 - S25
  • [40] Prevention of CV outcomes in antihyperglycaemic drug-naive patients with type 2 diabetes with, or at elevated risk of, ASCVD: to start or not to start with metformin
    Sattar, Naveed
    McGuire, Darren K.
    EUROPEAN HEART JOURNAL, 2021, 42 (26) : 2574 - 2576